Winship Logo

Clinical Trial Details

Back to clinical trials
Phase Expanded AccessNot Applicable

Expanded Access for Mezigdomide

Protocol: 2026P000991NCT: NCT06994117

Overview

This is an expanded access designed to provide access to Mezigdomide for eligible participants.

Eligibility

Age GroupsChild, Adult, Older Adult

Inclusion Criteria:

-

Exclusion Criteria:

-

Investigators
Location
Winship Cancer Institute
View on ClinicalTrials.gov